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Abstract
BACKGROUND: Diabetes is a chronic metabolic disease characterized with a rapid progression of prevalence in 
the past three decades, especially in countries with low- and middle-income. Next three decades, this number of 
diabetes in the world is expected to be doubled. Early diagnosis and appropriate management of diabetes are the 
primary way to prevent and delay cardiovascular complications.
AIM: The aim of this study was to estimate the prevalence of diabetes in Republic of Macedonia, analyzing increasing 
trends in the past 5 years.
PATIENTS AND METHODS: In this retrospective study, we used the data from National electronic system e-health 
which was performed in late 2014, which gives us nearly precise data, and we made statistical analysis for diabetes 
in the past 5 years (2015–2019).
RESULTS: In 2015, we have registered 103,480 patients with DM, in 2016, 108,130 patients, in 2017 114,408, in 
2018, 119,999, and, in 2019, 124,450 patients with DM. About 95% of patients are with T2DM and 4, 1% with T1DM. 
According the data from state statistical office for population of Republic of Macedonia, the prevalence of T2DM for 
the years 2015–2019 is as follows: 5,66% in 2015, 6.13% in 2016, 6.55% in 2017, 7,06% in 2018, and 7,2% in 2019.
CONCLUSIONS: The number of registered patients with diabetes in the past 5 years has grown up for 20970 or 
20%, in the past 5 years the number of patients with type 2 diabetes has grown up for 18272 patients or 11%. The 
prevalence of T2DM has increased for 1.54%. Involvement of primary health care professionals has improved the 
early diagnosis of type 2 diabetes.
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Introduction
Diabetes is a chronic metabolic disease 
characterized with a rapid progression of prevalence in 
the past three decades, especially in countries with low- 
and middle-income. The number of the patients with 
diabetes is expected to be doubled within the next three 
decades. Early diagnosis and appropriate management 
of diabetes are the primary way to prevent and delay 
CV complications. Together with population growth 
and ageing, this rise has led to a near quadrupling of 
the number of adults with diabetes worldwide [1]. For 
T2DM, which accounts for approximately 90% of the 
total, this rising trend can be attributed to ageing, a rapid 
increase in urbanization, and obesogenic environments. 
Incidence rates of T1D are also rising, contributing 
to the increase in diabetes prevalence. An additional 
contributor to the increased prevalence is better survival 
(in some populations) of people with diabetes through 
early detection, improved management of diabetes, 
and, consequently reduction in premature mortality [2]. 
Finally, the increasing number of younger adults with 
T2D in the recent years also contributes to the increase 
in overall T2D prevalence, through their longer survival.
Three in four people living with diabetes 
(352 million people - 72%) are of working age (i.e., 
between 20 and 64 years). This number is expected to 
increase to 417 million by 2030 and to 486 million by 2045. 
The prevalence of diabetes in adults (age 20–79 years) in 
the world is 8.3% and differs by continents and countries. 
In general, high income countries have higher prevalence 
(10,4%), and low-income countries have lower prevalence 
(4,0%) [3]. Republic of Macedonia is an upper-middle-
income country that has made great strides in reforming 
its economy over the past decade. As a part of this group 
it is estimated to have diabetes age adjusted comparative 
prevalence 9,3% [3], [4]. Until 2014, in our country, the 
prevalence of diabetes was as prediction number because 
of lack of national register for diabetes. As National 
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electronic system, e-health was performed in late 2014, 
which gives us nearly precise data; we can more precisely 
calculate the prevalence and incidence of diabetes.
The aim of this study was to estimate the 
prevalence of diabetes in Republic of Macedonia, 
analyzing increasing trends in the past 5 years.
Patients and Methods
This is retrospective study the data from the 
National System for Electronic Health Records – “Moj 
Termin” was used to calculate the prevalence and 
incidence of diabetes. We analyzed statistical national 
data for type 1 diabetes and type 2 diabetes for the 
period of 5 years, from 2015 to 2019. The data were 
collected from all levels of diabetes care (primary, 
secondary, and tertiary health care). We calculated the 
prevalence, incidence, and increasing rate of T1DM 
and T2DM for 5 years.
Results
The total number of registered patients with 
DM in 2015 was 103,480, in 2016 108,130 patients, in 
2017 114,408, in 2018 119,999, and in 2019 124,450 
patients. Of them, 95% had T2DM and 4,1% T1DM 
(Figure 1). The others (0.9%) had gestational diabetes 
or secondary diabetes.
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Figure 1: Number of patients with diabetes from 2015 to 2019 in 
R.N.M
Regarding the age, the most of Type 2 diabetes 
patients are of the age 20–79 years: In 2015, 99.52%, 
and, in 2019, 99.35% (Figure 2).
Based on the data from state statistical office 
for population of Republic of Macedonia (R.N.M.) 
(2083380), the prevalence of T2DM for the years 2015–
2019 is as follows: 4.97% in 2015, 5.19% in 2016, 
5.49% in 2017, 5.76% in 2018, and 6.12% in 2019. The 
age-adjusted comparative prevalence of diabetes for 
the age 20-79 year in a population 1,566,600 of the age 
20-79 years is: In 2015 6.09%, in 2016 6.49%, in 2017 is 
6.98%, in 2018 is 7,3%, and 7.6% in 2019. The annual 
incidence was 4.2% in 2016, 5.8% in 2017, 4.88% in 
2018, and 3.71 in 2019. The past 5 years, the number 
of people with diabetes in Republic of Macedonia is 
increased for 20% (20264 patients).
The past 5 years diabetes is increasing in 
children (0–14 years) and adolescents (15–19 years) 
(Table 1) with the increasing of incidence in the past 2 
years. The incidence for T1DM for age 0–14 years in 
Table 1: The number of patients with diabetes by age
Prevalence 2015 2016 2017 2018 2019
T1DM 0–14 years 156 192 227 272 312
T1DM 15–19 years 178 181 195 211 263
Total T1 DM 0–19 years 334 373 422 483 575
T2DM 0–14 years 28 39 54 64 76
T2DM 15–19 years 99 97 114 129 134
Total DM 0–19 years 461 509 590 676 785
T1DM 20–79 3780 3990 4210 4289 4500
T2 DM 20–79 91,772 97,790 105,205 110,346 114,550
Total DM 20–79 years 95,552 101,780 109,415 114,635 119,050
last 5 years is: In 2015, 0.9%, in 2016, 0.82%, in 2017, 
0.75%, in 2018, 0.94%, and in 2019, 0.78%.
According the working group, 56.1% of patients 
with diabetes are of age 25–65 years (Figure 3).
0
1000
2000
3000
4000
5000
25 27 29 31 33 35 37 39 41 43 45 47 49 51 53 55 57 59 61 63 65
T2DM of age 25-65 years in 2019
Figure 3: Distribution by productivity age of diabetes in 2019
According the treatment regime of diabetes, 
on insulin treatment 45,000 (36.16%). From them, 59% 
are on insulin analogues and 41% on human insulin 
therapy (Figure 4).
Discussion
Diabetes prevalence is increasing worldwide 
in the past three decades, especially in the countries 
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Figure 2: Distribution of patients by age from 20 to 79 years in 2019
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with low- and middle-income salary. The prevalence 
of diabetes in adults (age 20–79 years) in the world is 
8.3%. By continents, Europe has lower age adjusted 
comparative prevalence (6.3%) [3]. Republic of 
Macedonia, as European country according the 
projections, has been expected to have age adjusted 
comparative prevalence 9.3%, our result shows that 
age-adjusted comparative prevalence of diabetes for 
the age 20–79 year is 7.6% in 2019.
According the data from the IDF, Europe, 
North America, and Caribbean regions have the largest 
number of children with type 1 diabetes [5]. In the world, 
the number of children and adolescents (0–19 years) is 
0.2%. It is estimated that the incidence of type 1 diabetes 
among children and adolescents is increasing in many 
countries particularly in those aged <15 years [6]. The 
overall annual increase is estimated to be around 3% 
with strong indications of geographic differences; the 
slow increase of incidence of T1DM in this age in our 
country (0.75–0.9%) is higher than the world but less 
than European average. Type 2 diabetes in children 
has increased in frequency around the world over the 
past two decades of the age 0–19 years and should 
be the focus of early intervention in the prevention 
program such as healthy diet and physical activities 
due to increase of body mass index in this group of 
population [7], [8].
The percentage of affected persons with 
diabetes of the working age 25–65 years is 56, 1%. 
Comparing with world data, 72% of people with diabetes 
are in the working age of 20–64 years [3].
Conclusion
The number of registered patients with 
diabetes in the past 5 years has increased cumulatively 
for 20,264 or 20%, in the past 5 years, the number of 
patients with type 2 diabetes has increased cumulatively 
for 18,272 patients or 11%. The prevalence of T2DM 
has increased for 1.54%. Age- adjusted comparative 
prevalence of diabetes for the age 20–79 year has 
increased for 1.65%. Involvement of primary health-
care professionals has improved the early diagnosis 
of type 2 diabetes. The electronic system of gathering 
data of patients is powerful tool for prompt statistical 
analysis, also gives opportunity for establishing the 
National registry of DM in future.
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Figure 4: Insulin therapy in 2019 (analogs vs. human insulin)
